Filter
2852
Filtered Results: 2852
Text search:
Drug
Resistance
Featured
Recommendations
299
New Publications
743
Language
Document type
No document type
1631
Studies & Reports
434
Guidelines
429
Manuals
121
Strategic & Response Plan
95
Fact sheets
56
Training Material
42
Situation Updates
15
Infographics
12
Resource Platforms
6
Online Courses
5
Brochures
3
Videos
3
Countries / Regions
India
155
Global
86
South Africa
80
Kenya
79
Western and Central Europe
75
Ethiopia
60
Uganda
51
Tanzania
49
Nepal
48
Eastern Europe
47
Africa
44
Zambia
41
Nigeria
39
Liberia
37
Latin America and the Carribbean
36
Sierra Leone
34
Malawi
32
Philippines
31
Myanmar / Burma
30
Ghana
29
Bangladesh
28
Rwanda
27
Asia
24
Namibia
24
Cambodia
23
Lesotho
22
South–East Asia Region
22
Zimbabwe
20
Ukraine
19
Russia
19
Indonesia
19
Senegal
17
Botswana
14
Congo, Democratic Republic of
13
Cameroon
12
Mozambique
12
Colombia
11
Venezuela
10
Syria
9
Thailand
8
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Germany
7
East and Southern Africa
7
Argentina
7
Pakistan
7
Tajikistan
6
USA
6
Haiti
6
Benin
5
China
5
Laos
5
Guinea
5
Vietnam
5
Georgia
5
Peru
4
Western Pacific Region
4
Brazil
4
Sudan
4
Iraq
4
North Macedonia
3
El Salvador
3
Iran
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
North America
3
Uruguay
3
Lebanon
3
Sri Lanka
3
Central African Republic
3
Bhutan
3
South Sudan
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Moldova
2
Yemen
2
Mali
2
Libya
2
Ecuador
2
Madagascar
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Guinea-Bissau
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Oman
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1002
Clinical Guidelines
293
Public Health
122
Women & Child Health
81
Key Resources
72
Capacity Building
37
Pharmacy & Technologies
36
Annual Report MEDBOX
1
Toolboxes
TB
506
HIV
346
AMR
328
NTDs
120
Mental Health
113
COVID-19
94
Pharmacy
75
Rapid Response
63
Caregiver
49
Planetary Health
48
Malaria
43
NCDs
37
Ebola & Marburg
33
Global Health Education
32
Refugee
31
Health Financing Toolbox
21
Polio
17
Conflict
14
Cholera
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
Aлгоритм лабораторной диагностики и мониторинга лечения туберкулеза легких и туберкулеза с лекарственной устойчивостью на основе применения современных быстрых...
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
The GAP articulates five objectives for tackling AMR, and sets out the tasks required to achieve them, highlighting
roles and responsibilities for country governments, the One Health Tripartite organizations (FAO, OIE and WHO) and other national and international partners. To ensure that all stakeh...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
L’antibiorésistance constitue aujourd’hui l’un des grands défis à relever à l’échelle mondiale. Il s’agit d’une menace de santé publique majeure qui impose une mobilisation déterminée et durable de l’ensemble des acteurs impliqués dans le cycle de vie des antibiotiques, afin d...
The framework is to be used as a reference guide, applied according to local priorities and needs, and targeted at academic institutions, educators, accreditation bodies, regulatory agencies and other users. The ultimate aim is to ensure that all health workers are equipped with the requisite compet...
Примеры надлежащей практики в области укрепления систем здравоохранения с целью профилактики и лечения туберкулеза и лекарственно-устойчивого туберкулеза
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2011 and 2012 data currently available from their re...
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o...
